Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 26, 2003

View Archived Issues

Two cases of OCD behavior described in children after receiving risperidone

Beneficial effects reported for FR-167653 in experimental autoimmune myocarditis

Local methotrexate reported to inhibit tumor progression in mice

High remission rates obtained with sertraline in OCD

Good toxicity profile reported for squalamine in patients with solid tumors

FDA accepts resubmission of Emsam NDA

Selective agonists of thyroid hormone receptors may have utility in obesity

Phase I/II trials cleared for topical PTH (7-34) in chemotherapy-induced alopecia

German permits for 1D09C3 pave way for E.U. clinical trials

AD-237 enters phase IIa study for COPD

New joint venture to develop bioresorbable drug-eluting cardiovascular stent

Novel HCV NS5B inhibitors prepared and tested at GSK

Novel MCH receptor modulators under study at Neurogen

Bayer team presents new Rho kinase inhibitors in recent patent

New IMPDH inhibitors and their use in psoriasis, arthritis and transplant rejection

New LXR modulators in Pharmacia development pipeline

Cytochroma discovers new retinoic acid metabolizing cytochrome P450

Canadian approval for initiation of Actipore trial

Effect of DN-101 on chemotherapy for NSCLC evaluated in new phase I/II trial

Approvable letter for Zometa for patients with bone metastases from advanced cancer

Approval for pediatric extension of Fludara

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...